Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice
- PMID: 12009758
- DOI: 10.1006/exnr.2002.7882
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice
Abstract
Human alpha-synuclein (halpha-SYN) is implicated in the Parkinson's disease phenotype (PDP) based on a variety of studies in man, animal models, and in vitro studies. The normal function of halpha-SYN and the mechanism by which it contributes to the PDP remains unclear. We created transgenic mice expressing either wild-type (hwalpha-SYN) or a doubly mutated (hm2alpha-SYN) form of halpha-SYN under control of the 9-kb rat tyrosine hydroxylase promoter. These mice expressed halpha-SYN in cell bodies, axons, and terminals of the nigrostriatal system. The expression of halpha-SYN in nigrostriatal terminals produced effects in both constructs resulting in increased density of the dopamine transporter and enhanced toxicity to the neurotoxin MPTP. Expression of hm2alpha-SYN reduced locomotor responses to repeated doses of amphetamine and blocked the development of sensitization. Adult hwalpha-SYN-5 transgenic mice had unremarkable dopaminergic axons and terminals, normal age-related measures on two motor coordination screens, and normal age-related measures of dopamine (DA) and its metabolites. Adult hm2alpha-SYN-39 transgenic mice had abnormal axons and terminals, age-related impairments in motor coordination, and age-related reductions in DA and its metabolites. Expression of hm2alpha-SYN adversely affects the integrity of dopaminergic terminals and leads to age-related declines in motor coordination and dopaminergic markers.
Copyright 2002 Elsevier Science (USA).
Similar articles
-
Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.Exp Neurol. 2001 May;169(1):83-95. doi: 10.1006/exnr.2001.7638. Exp Neurol. 2001. PMID: 11312561
-
Selective alterations of gene expression in mice induced by MPTP.Synapse. 2005 Jan;55(1):45-51. doi: 10.1002/syn.20089. Synapse. 2005. PMID: 15499605
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
The dopamine transporter: a crucial component regulating dopamine transmission.Mov Disord. 1997 Sep;12(5):629-33. doi: 10.1002/mds.870120502. Mov Disord. 1997. PMID: 9380041 Review.
-
Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.Adv Neurol. 1993;60:133-9. Adv Neurol. 1993. PMID: 8420130 Review. No abstract available.
Cited by
-
Model fusion, the next phase in developing animal models for Parkinson's disease.Neurotox Res. 2007 Apr;11(3-4):219-40. doi: 10.1007/BF03033569. Neurotox Res. 2007. PMID: 17449461 Review.
-
Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: positive and negative effects.Brain Res. 2014 Mar 6;1550:47-60. doi: 10.1016/j.brainres.2014.01.010. Epub 2014 Jan 21. Brain Res. 2014. PMID: 24463035 Free PMC article.
-
Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in Mice.Neuroscience. 2020 Aug 10;441:58-64. doi: 10.1016/j.neuroscience.2020.05.047. Epub 2020 Jun 2. Neuroscience. 2020. PMID: 32502569 Free PMC article.
-
Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons.Mol Neurodegener. 2009 Jul 24;4:34. doi: 10.1186/1750-1326-4-34. Mol Neurodegener. 2009. PMID: 19630976 Free PMC article.
-
UBA52 Is Crucial in HSP90 Ubiquitylation and Neurodegenerative Signaling during Early Phase of Parkinson's Disease.Cells. 2022 Nov 25;11(23):3770. doi: 10.3390/cells11233770. Cells. 2022. PMID: 36497031 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous